Jeffrey H Newcorn

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Aortic Dissection

Attention Deficit Hyperactivity Disorder

Top Venues

Molecular psychiatry

Cornell University Medical College

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cornell University Medical College

United States

Assistant Professor :: Psychiatry

Icahn School of Medicine at Mount Sinai

United States

Director :: Student/Trainee Mental Health Program

Mount Sinai Health System

United States

Director :: Pediatric Psychopharmacology

Mount Sinai Medical Center

United States

Director :: Division of ADHD and Learning Disorders

Mount Sinai School of Medicine

United States

Associate Professor :: Psychiatry and Pediatrics

Mount Sinai School of Medicine

United States

Director :: Division of Child and Adolescent Psychiatry

Mount Sinai School of Medicine

United States

Director of Residency Training :: Psychiatry

Mount Sinai School of Medicine

United States

Director of Residency Training :: Psychiatry

Mount Sinai School of Medicine

United States

Assistant Professor :: Psychiatry

Mount Sinai Hospital

United States

Director :: Child Inpatient Psychiatry

Mount Sinai School of Medicine

United States

Instructor :: Psychiatry

NewYork Hospital/Westchester Division

United States

Assistant Unit Chief :: Adolescent and Eating Disorders

Cornell University Medical College

United States

Instructor :: Psychiatry

NewYork Hospital/Westchester Division

United States

Staff Psychiatrist :: Adolescent and Eating Disorders

Tufts New England Medical Center

United States

Clinical Instructor :: Psychiatry

Publications

Kathrine Bang Madsen, Thalia K Robakis, Xiaoqin Liu, Natalie C Momen, Henrik Larsson, Julie Werenberg Dreier, Helene Kildegaard, Jane Bjerg Groth, Jeffrey H Newcorn, Per Hove Thomsen, Trine Munk-Olsen, Veerle Bergink
In utero exposure to ADHD medication and long-term offspring outcomes. Molecular psychiatry (2023)
Kathrine Bang Madsen, Thalia K Robakis, Xiaoqin Liu, Natalie C Momen, Henrik Larsson, Julie Werenberg Dreier, Helene Kildegaard, Jane Bjerg Groth, Jeffrey H Newcorn, Per Hove Thomsen, Trine Munk-Olsen, Veerle Bergink
In utero exposure to ADHD medication and long-term offspring outcomes. Molecular psychiatry (2023)
Samuele Cortese, Jeffrey H Newcorn, David R Coghill
A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD). CNS drugs 35 (10) (2021)
Tim L Wigal, Jeffrey H Newcorn, Nelson Handal, Sharon B Wigal, Ioulietta Mulligan, Virginia D Schmith, Eric Konofal
A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS drugs 32 (3) (2019)
Jeffrey H Newcorn, Peter Nagy, Ann C Childress, Glen Frick, Brian Yan, Steven Pliszka
Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder. CNS drugs 31 (11) (2018)